Skip to main content
OpenTrials

Clinical trial condition

Carcinoma, Bronchogenic

Explore clinical trials studying Carcinoma, Bronchogenic. Study availability and eligibility vary by location and protocol.

5,265 public trials 1,195 recruiting studies
Refine in advanced search Browse all conditions

Carcinoma, Bronchogenic trial results

Recruiting

Clinical Study of Ivonescimab for First-line Treatment of Metastatic NSCLC Patients With High PD-L1

NCT06767514

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations
  • Clinical Study Site Chandler, Arizona, United States
  • Clinical Study Site Phoenix, Arizona, United States
  • Clinical Study Site Hot Springs, Arkansas, United States
  • Clinical Study Sites Jonesboro, Arkansas, United States
View all 274 locations
View Trial Details
Recruiting

A Safety and Efficacy Study of EIK1001 in Combination With Pembrolizumab and Chemotherapy in Participants With Stage 4 Non-Small Cell Lung Cancer.

NCT07365319

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +9 more
Locations
  • Southern Cancer Center, P.C. Daphne, Alabama, United States
  • Los Angeles Cancer Network Glendale, California, United States
  • Rocky Mountain Cancer Centers, LLP Pueblo, Colorado, United States
  • NYU Langone Hospital Long Island Mineola, New York, United States
View all 18 locations
View Trial Details
Recruiting

Testing the Addition of a Type of Drug Called Immunotherapy to the Usual Chemotherapy Treatment for Non-small Cell Lung Cancer, an ALCHEMIST Treatment Trial (Chemo-IO [ACCIO])

NCT04267848

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +13 more
Locations
  • Anchorage Associates in Radiation Medicine Anchorage, Alaska, United States
  • Anchorage Radiation Therapy Center Anchorage, Alaska, United States
  • Alaska Breast Care and Surgery LLC Anchorage, Alaska, United States
  • Alaska Oncology and Hematology LLC Anchorage, Alaska, United States
View all 1150 locations
View Trial Details
Recruiting

A Study to Investigate Safety of AZD6750 in Adult Participants With Select Advanced or Metastatic Solid Tumors

NCT07115043

Conditions
Adenocarcinoma, Breast Diseases, Breast Neoplasms, +58 more
Locations
  • Research Site Grand Rapids, Michigan, United States
  • Research Site St Louis, Missouri, United States
  • Research Site Pittsburgh, Pennsylvania, United States
  • Research Site Houston, Texas, United States
View all 13 locations
View Trial Details
Recruiting

BGB-43395 Alone or as Part of Combination Therapies in Participants With Breast Cancer and Other Advanced Solid Tumors

NCT06120283

Conditions
Advanced Breast Cancer, Advanced Solid Tumor, Breast Diseases, +20 more
Locations
  • Sarah Cannon Research Institute (Scri) At Health One Denver, Colorado, United States
  • Florida Cancer Specialists and Research Institute Lake Mary, Florida, United States
  • Karmanos Cancer Institute Detroit, Michigan, United States
  • Washington University School of Medicine St Louis, Missouri, United States
View all 62 locations
View Trial Details
Recruiting

DAREON ® -Lung-1: A Study in People With Advanced Small Cell Lung Cancer to Compare Obrixtamig Plus Atezolizumab, Carboplatin, and Etoposide Treatment With Standard Chemoimmunotherapy

NCT07472517

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Extensive-stage Small Cell Lung Cancer (ES-SCLC), +9 more
Locations
  • Infirmary Cancer Care Mobile, Alabama, United States
  • University of Arkansas for Medical Sciences Little Rock, Arkansas, United States
  • Bioresearch Partner - Hialeah Hospital Hialeah, Florida, United States
  • Emory University Atlanta, Georgia, United States
View all 245 locations
View Trial Details

Related conditions